The Current Ratio as of November 2025 (TTM) for GreenLight Biosciences Holdings (GRNA) is 2.01

According to GreenLight Biosciences Holdings’s latest financial reports and current stock price. The company's current Current Ratio is 2.01. This represents a change of 3.57% compared to the average of 1.94 of the last 4 quarters.

GreenLight Biosciences Holdings (GRNA) Historical Current Ratio (quarterly & annually)

How has GRNA Current Ratio performed in the past?

The mean historical Current Ratio of GreenLight Biosciences Holdings over the last ten years is 3.54. The current 2.01 Current Ratio has changed 5.57% with respect to the historical average. Over the past ten years (40 quarters), GRNA's Current Ratio was at its highest in in the December 2020 quarter at 6.98. The Current Ratio was at its lowest in in the December 2021 quarter at 0.04.

GreenLight Biosciences Holdings (GRNA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of GreenLight Biosciences Holdings Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GreenLight Biosciences Holdings (GRNA) Average Current Ratio

How has GRNA Current Ratio performed in the past?

The current Current Ratio of GreenLight Biosciences Holdings (GRNA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

GreenLight Biosciences Holdings (GRNA) Current Ratio vs. Peers

How is GRNA’s Current Ratio compared to its peers?

GreenLight Biosciences Holdings’s Current Ratio is greater than Lunai Bioworks Inc. (0.04), greater than bluebird bio, Inc. (0.55), less than Spyre Therapeutics, Inc. (10.90), greater than Rein Therapeutics Inc. (0.90), less than Magenta Therapeutics, Inc. (17.35), less than AlloVir, Inc. (12.89), greater than Pluristem Therapeutics Inc. (0.53), greater than ERYTECH Pharma S.A. (1.06), less than LianBio (74.19), less than Satsuma Pharmaceuticals, Inc. (6.75),

Build a custom stock screener for GreenLight Biosciences Holdings (GRNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GreenLight Biosciences Holdings using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GreenLight Biosciences Holdings (GRNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GreenLight Biosciences Holdings or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.